Implantation of an Intrathecal Drug Administration System -A report of two cases-

Opioids profoundly inhibit evoked discharges of spinal nociceptive neurons, thereby inhibiting the transmission of pain. Intrathecal administration of opioids using implantable continuous infusion systems is an effective method of pain relief when other treatments have failed, as well as for patients with adequate analgesia on high dose therapy that produces unacceptable side effects. We report two cases of intrathecal pump implantation performed in patients suffering from intractable chronic pain. A test dose of 3 mg morphine was injected into the epidural space. No side effects were noted and patients experienced considerable pain relief. Implantation was performed one day after the test. The initial intrathecal morphine delivery dose was half of the equivalent dose of daily oral intake opioids and the infusion rate was increased gradually under close observation for opioid side effects. Two days post-implantation, both patients were discharged without any complications.

[1]  P. Felleiter,et al.  Device-related complications of long-term intrathecal drug therapy via implanted pumps , 2008, Spinal Cord.

[2]  B. Kim,et al.  Intrathecal Catheter and Subcutaneous Access Port Implantation in Pain Management for Terminal Cancer Patient: A case report , 2007 .

[3]  E. Kravitz,et al.  Intrathecal opioid treatment for chronic non-malignant pain: a 3-year prospective study , 2004, Pain.

[4]  S. Hassenbusch,et al.  Management of intrathecal catheter-tip inflammatory masses: a consensus statement. , 2002, Pain medicine.

[5]  Thomas J. Smith,et al.  Randomized clinical trial of an implantable drug delivery system compared with comprehensive medical management for refractory cancer pain: impact on pain, drug-related toxicity, and survival. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  G. Treharne,et al.  Bmc Musculoskeletal Disorders Long-term Experience with Implanted Intrathecal Drug Administration Systems for Failed Back Syndrome and Chronic Mechanical Low Back Pain , 2022 .

[7]  K. Follett,et al.  A prospective study of catheter-related complications of intrathecal drug delivery systems. , 2000, Journal of pain and symptom management.

[8]  H. Williams,et al.  Systematic review of treatments for atopic eczema. , 2000, Health technology assessment.

[9]  Williams Je,et al.  Intrathecal pumps for giving opioids in chronic pain: a systematic review. , 2000, Health technology assessment.

[10]  Hassenbusch Sj.  Cost modeling for alternate routes of administration of opioids for cancer pain. , 1999 .

[11]  S. Mercadante.  Problems of long-term spinal opioid treatment in advanced cancer patients , 1999, Pain.

[12]  W. Winkelmüller,et al.  Long-term effects of continuous intrathecal opioid treatment in chronic pain of nonmalignant etiology. , 1996, Journal of neurosurgery.

[13]  E. Krames.  Intraspinal opioid therapy for chronic nonmalignant pain: current practice and clinical guidelines. , 1996, Journal of pain and symptom management.

[14]  R. Penn,et al.  Intraspinal morphine for chronic pain: a retrospective, multicenter study. , 1996, Journal of pain and symptom management.

[15]  E. Krames.  Intrathecal infusional therapies for intractable pain: patient management guidelines. , 1993, Journal of pain and symptom management.

[16]  K. Drasner,et al.  Cauda Equina Syndrome After Continuous Spinal Anesthesia , 1991, Anesthesia and analgesia.

[17]  T. Yaksh,et al.  Continuous low-dose intrathecal morphine administration in the treatment of chronic pain of malignant origin. , 1981, Mayo Clinic proceedings.

[18]  M. H. Alper.  Intrathecal morphine: a new method of obstetric analgesia? , 1979, Anesthesiology.

[19]  John E. Thomas,et al.  Pain relief by intrathecally applied morphine in man. , 1979, Anesthesiology.

[20]  T. Yaksh,et al.  Analgesia mediated by a direct spinal action of narcotics. , 1976, Science.